These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 22611049)

  • 1. Lower serum hepcidin and greater parenchymal iron in nonalcoholic fatty liver disease patients with C282Y HFE mutations.
    Nelson JE; Brunt EM; Kowdley KV;
    Hepatology; 2012 Nov; 56(5):1730-40. PubMed ID: 22611049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HFE genotype, parenchymal iron accumulation, and liver fibrosis in patients with nonalcoholic fatty liver disease.
    Valenti L; Fracanzani AL; Bugianesi E; Dongiovanni P; Galmozzi E; Vanni E; Canavesi E; Lattuada E; Roviaro G; Marchesini G; Fargion S
    Gastroenterology; 2010 Mar; 138(3):905-12. PubMed ID: 19931264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HFE mutations, hepatic iron, and fibrosis: ethnic-specific association of NASH with C282Y but not with fibrotic severity.
    Chitturi S; Weltman M; Farrell GC; McDonald D; Kench J; Liddle C; Samarasinghe D; Lin R; Abeygunasekera S; George J
    Hepatology; 2002 Jul; 36(1):142-9. PubMed ID: 12085358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum ferritin levels are associated with vascular damage in patients with nonalcoholic fatty liver disease.
    Valenti L; Swinkels DW; Burdick L; Dongiovanni P; Tjalsma H; Motta BM; Bertelli C; Fatta E; Bignamini D; Rametta R; Fargion S; Fracanzani AL
    Nutr Metab Cardiovasc Dis; 2011 Aug; 21(8):568-75. PubMed ID: 20392616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A time course of hepcidin response to iron challenge in patients with HFE and TFR2 hemochromatosis.
    Girelli D; Trombini P; Busti F; Campostrini N; Sandri M; Pelucchi S; Westerman M; Ganz T; Nemeth E; Piperno A; Camaschella C
    Haematologica; 2011 Apr; 96(4):500-6. PubMed ID: 21173098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blunted increase in serum hepcidin as response to oral iron in HFE-hemochromatosis.
    Sangwaiya A; Manglam V; Busbridge M; Thursz M; Arnold J
    Eur J Gastroenterol Hepatol; 2011 Aug; 23(8):721-4. PubMed ID: 21654321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HFE C282Y mutations are associated with advanced hepatic fibrosis in Caucasians with nonalcoholic steatohepatitis.
    Nelson JE; Bhattacharya R; Lindor KD; Chalasani N; Raaka S; Heathcote EJ; Miskovsky E; Shaffer E; Rulyak SJ; Kowdley KV
    Hepatology; 2007 Sep; 46(3):723-9. PubMed ID: 17680648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of HFE mutations and relation to serum iron status in patients with chronic hepatitis C and patients with nonalcoholic fatty liver disease in Taiwan.
    Lin TJ; Lin CL; Wang CS; Liu SO; Liao LY
    World J Gastroenterol; 2005 Jul; 11(25):3905-8. PubMed ID: 15991291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-alcoholic steatohepatitis and iron: increased prevalence of mutations of the HFE gene in non-alcoholic steatohepatitis.
    Bonkovsky HL; Jawaid Q; Tortorelli K; LeClair P; Cobb J; Lambrecht RW; Banner BF
    J Hepatol; 1999 Sep; 31(3):421-9. PubMed ID: 10488699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blunted hepcidin response to oral iron challenge in HFE-related hemochromatosis.
    Piperno A; Girelli D; Nemeth E; Trombini P; Bozzini C; Poggiali E; Phung Y; Ganz T; Camaschella C
    Blood; 2007 Dec; 110(12):4096-100. PubMed ID: 17724144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An epidemiologic study on the incidence and significance of HFE mutations in a Korean cohort with nonalcoholic fatty liver disease.
    Lee SH; Jeong SH; Lee D; Lee JH; Hwang SH; Cho YA; Park YS; Hwang JH; Kim JW; Kim N; Lee DH; Kang W
    J Clin Gastroenterol; 2010 Aug; 44(7):e154-61. PubMed ID: 20216079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HFE mutations modulate the effect of iron on serum hepcidin-25 in chronic hemodialysis patients.
    Valenti L; Girelli D; Valenti GF; Castagna A; Como G; Campostrini N; Rametta R; Dongiovanni P; Messa P; Fargion S
    Clin J Am Soc Nephrol; 2009 Aug; 4(8):1331-7. PubMed ID: 19541813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indices of iron homeostasis in asymptomatic subjects with HFE mutations and moderate ferritin elevation during iron removal treatment.
    Infanti L; Leitner G; Moe MK; Pehlic V; Benkert P; Cattaneo M; Holbro A; Passweg J; Worel N; Buser A
    Blood Cells Mol Dis; 2022 Nov; 97():102689. PubMed ID: 35780678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in hepatic phenotype between hemochromatosis patients with HFE C282Y homozygosity and other HFE genotypes.
    Cheng R; Barton JC; Morrison ED; Phatak PD; Krawitt EL; Gordon SC; Kowdley KV
    J Clin Gastroenterol; 2009 Jul; 43(6):569-73. PubMed ID: 19359997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The A736V TMPRSS6 polymorphism influences hepatic iron overload in nonalcoholic fatty liver disease.
    Valenti L; Rametta R; Dongiovanni P; Motta BM; Canavesi E; Pelusi S; Pulixi EA; Fracanzani AL; Fargion S
    PLoS One; 2012; 7(11):e48804. PubMed ID: 23144979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The prevalence of peripheral iron overload and the presence of HFE gene (H63D) mutation among the Korean patients with nonalcoholic fatty liver disease].
    Lee D; Jeong SH; Lee M; Cho YA; Kim JW; Park Y; Hwang JH; Kim NY; Lee DH
    Korean J Hepatol; 2007 Jun; 13(2):174-84. PubMed ID: 17585191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver.
    Bugianesi E; Manzini P; D'Antico S; Vanni E; Longo F; Leone N; Massarenti P; Piga A; Marchesini G; Rizzetto M
    Hepatology; 2004 Jan; 39(1):179-87. PubMed ID: 14752836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relative contribution of iron genes, dysmetabolism and hepatitis C virus (HCV) in the pathogenesis of altered iron regulation in HCV chronic hepatitis.
    Valenti L; Pulixi EA; Arosio P; Cremonesi L; Biasiotto G; Dongiovanni P; Maggioni M; Fargion S; Fracanzani AL
    Haematologica; 2007 Aug; 92(8):1037-42. PubMed ID: 17640859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonalcoholic fatty liver disease and HFE gene mutations: a Polish study.
    Raszeja-Wyszomirska J; Kurzawski G; Lawniczak M; Miezynska-Kurtycz J; Lubinski J
    World J Gastroenterol; 2010 May; 16(20):2531-6. PubMed ID: 20503453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of evidence for the pathogenic role of iron and HFE gene mutations in Brazilian patients with nonalcoholic steatohepatitis.
    Deguti MM; Sipahi AM; Gayotto LC; Palácios SA; Bittencourt PL; Goldberg AC; Laudanna AA; Carrilho FJ; Cançado EL
    Braz J Med Biol Res; 2003 Jun; 36(6):739-45. PubMed ID: 12792703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.